Thursday, August 29, 2013

No down payment medical, dental and healthcare provider practice financing here! + More News: US FDA probes brain infection in patient on Novartis's MS drug + MORE 08/29/2013


Medical Professional financing for your medical practice!  Learn how to get funding with medical practice financing. More Info Here!



Call: 904-551-6090




Over the years we have been able to finance a lot of start up medical practice units with excellent services. The great repayments rates that are stated by the company will give you the chance to order your finances well. All the low repayment rates are aimed at financing your financial program by virtue that it was specifically designed to help fresh medical doctors who are in need of financial assistance to start up their medical practice. With confidence, you should make our company your financial source as we are dedicated to make your dreams a reality.


Read The Interesting Snippets Below For Exciting Health-Care News!





Percent of depressed men comparable to women: study


– http://www.reuters.com/healthNews


NEW YORK (Reuters Health) – The proportion of men who experience symptoms of depression may be similar to the proportion of women with depression when doctors look for non-traditional symptoms, according to a new study.

Continue Reading On http://www.reuters.com/healthNews »




Aug 29 (Reuters) – The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday:

Continue Reading On http://www.reuters.com »




(Reuters) – The U.S. Food and Drug Administration said it was investigating a case of a rare and serious brain infection that developed in a patient in Europe, who was being treated with Novartis’s multiple sclerosis drug, Gilenya.

Continue Reading On http://www.reuters.com/healthNews »




LONDON, Aug 29 (Reuters) – Scientists have found a genetic mechanism in mice that hampers their body clock’s ability to adjust to changes in patterns of light and dark, and say their results could someday lead to the development of drugs to combat jet lag.

Continue Reading On http://www.reuters.com »




Aug 29 (Reuters) – The U.S. Food and Drug Administration said it was investigating a case of a rare and serious brain infection that developed in a patient in Europe, who was being treated with Novartis’s multiple sclerosis drug, Gilenya.

Continue Reading On http://www.reuters.com »




Aug 29 (Reuters) – Aetna Inc, the No. 3 U.S. health insurer, said on Thursday it has decided not to sell insurance on New York’s individual health insurance exchange, part of the country’s healthcare reform.

Continue Reading On http://www.reuters.com »




No down payment medical, dental and healthcare provider practice financing here! + More News: US FDA probes brain infection in patient on Novartis's MS drug + MORE 08/29/2013

1 comment:

Anonymous said...

Thanks on your marvelous posting! I actually enjoyed reading it, you may be a great author.

I will be sure to bookmark your blog and may come back very soon. I want to encourage yourself to continue your great work,
have a nice afternoon!

Here is my web blog sex